Frontiers in Pharmacology (May 2018)

A Review on the Effect of Traditional Chinese Medicine Against Anthracycline-Induced Cardiac Toxicity

  • Xinyu Yang,
  • Xinyu Yang,
  • Nian Liu,
  • Xinye Li,
  • Xinye Li,
  • Yihan Yang,
  • Yihan Yang,
  • Xiaofeng Wang,
  • Linling Li,
  • Le Jiang,
  • Yonghong Gao,
  • Hebin Tang,
  • Yong Tang,
  • Yanwei Xing,
  • Hongcai Shang

DOI
https://doi.org/10.3389/fphar.2018.00444
Journal volume & issue
Vol. 9

Abstract

Read online

Anthracyclines are effective agents generally used to treat solid-tumor and hematologic malignancies. The use of anthracyclines for over 40 years has improved cancer survival statistics. Nevertheless, the clinical utility of anthracyclines is limited by its dose-dependent cardiotoxicity that adversely affects 10–30% of patients. Anthracycline-induced cardiotoxicity may be classified as acute/subacute or chronic/late toxicity and leads to devastating adverse effects resulting in poor quality of life, morbidity, and premature mortality. Traditional Chinese medicine has a history of over 2,000 years, involving both unique theories and substantial experience. Several studies have investigated the potential of natural products to decrease the cardiotoxic effects of chemotherapeutic agents on healthy cells, without negatively affecting their antineoplastic activity. This article discusses the mechanism of anthracycline-induced cardiotoxicity, and summarizes traditional Chinese medicine treatment for anthracycline-induced heart failure (HF), cardiac arrhythmia, cardiomyopathy, and myocardial ischemia in recent years, in order to provide a reference for the clinical prevention and treatment of cardiac toxicity.

Keywords